{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:59:22Z","timestamp":1768557562711,"version":"3.49.0"},"reference-count":9,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bullous pemphigoid is an autoimmune blistering dermatosis with separation of the epidermis from the dermis. This disease process is common among elderly patients and manifests with subepidermal vesicles and tense bullae. Patients with bullous pemphigoid are more likely to have also received a previous diagnosis of a neurologic disorder. Gabapentin is an antiepileptic that is used to manage neuropathic pain. The authors describe, to their knowledge, the first report of gabapentin-induced bullous pemphigoid in an elderly man with no history of rashes or reactions to other medications.<\/jats:p>","DOI":"10.7556\/jaoa.2017.034","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T23:32:29Z","timestamp":1488238349000},"page":"191-193","source":"Crossref","is-referenced-by-count":3,"title":["Gabapentin-Induced Bullous Pemphigoid"],"prefix":"10.1515","volume":"117","author":[{"given":"Avram","family":"Flamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarina","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Dufresne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"issue":"4","key":"2022022617150907751_j_jaoa.2017.034_ref_001","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1172\/JCI116368","article-title":"Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.","volume":"91","author":"Ishiko","year":"1993","journal-title":"J Clin Invest"},{"issue":"5","key":"2022022617150907751_j_jaoa.2017.034_ref_002","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/000155502320624267","article-title":"Gabapentin-induced bullous pemphigoid.","volume":"82","author":"Zachariae","year":"2002","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"2022022617150907751_j_jaoa.2017.034_ref_003","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: a UK case-control study.","volume":"149","author":"Lloyd-Lavery","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"5","key":"2022022617150907751_j_jaoa.2017.034_ref_004","first-page":"455","article-title":"Stevens-Johnson syndrome associated with gabapentin.","volume":"105","author":"Gonzalez-Sicilia","year":"1998","journal-title":"Am J Med"},{"issue":"1","key":"2022022617150907751_j_jaoa.2017.034_ref_005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-199902000-00022","article-title":"Skin eruption with gabapentin in a patient with repeated AED-induced Stevens-Johnson\u2019s syndrome.","volume":"21","author":"DeToledo","year":"1999","journal-title":"Ther Drug Monit"},{"issue":"3","key":"2022022617150907751_j_jaoa.2017.034_ref_006","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study.","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol"},{"issue":"11","key":"2022022617150907751_j_jaoa.2017.034_ref_007","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archdermatol.2010.322","article-title":"The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study.","volume":"146","author":"Taghipour","year":"2010","journal-title":"Arch Dermatol"},{"issue":"5","key":"2022022617150907751_j_jaoa.2017.034_ref_008","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-4362.1991.tb03867.x","article-title":"Pemphigus and bullous pemphigoid due to drugs.","volume":"30","author":"Ruocco","year":"1991","journal-title":"Int J Dermatol"},{"issue":"5","key":"2022022617150907751_j_jaoa.2017.034_ref_009","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI117196","article-title":"92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.","volume":"93","author":"St\u00e5hle-B\u00e4ckdahl","year":"1994","journal-title":"J Clin Invest"}],"container-title":["Journal of Osteopathic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2017.034\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2017.034\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T17:15:39Z","timestamp":1645895739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2017.034\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":9,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,1]]},"published-print":{"date-parts":[[2017,3,1]]}},"alternative-id":["10.7556\/jaoa.2017.034"],"URL":"https:\/\/doi.org\/10.7556\/jaoa.2017.034","relation":{},"ISSN":["2702-3648"],"issn-type":[{"value":"2702-3648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]}}}